1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Cardiovascular Devices Market Trends
  5. > Non-Vascular Stents - 5EU Analysis and Market Forecasts

Non-Vascular Stents - 5EU Analysis and Market Forecasts

Summary

Non-vascular stent technology has evolved over the years such that these devices are routinely used in clinical practice for different indications. Although it is a mature market, both short and long-term complications associated with non-vascular stents continue to persist. This report focuses on four market categories within the non-vascular stent segment, which includes enteral stents (esophageal, gastroduodenal and colonic stents), pancreatic and biliary stents, airways stents and urinary tract stents (ureteral, prostate and urethral stents). The overall non-vascular stent market has been estimated in this report, which covers France, Germany, Italy, Spain, and the UK (EU5) up to 2021. The report provides an investigation of unmet needs, future adoption trends and compound annual growth rates (CAGR) for each geography and market segment. In addition, this report presents the current market drivers and barriers which will influence the future market growth of non-vascular stents in the EU5.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights

Key Questions Answered

- (Q). What is the current and future non-vascular stent market outlook in the developed and emerging markets? (Q). What trends are affecting the global non-vascular stents market?
- (Q). Which are the key, high growth markets that stent manufacturers should expand into? (Q). What non-vascular stent segments are growing the fastest?
- There are a few significant unmet needs. (Q). What are these unmet needs? (Q). What is the scope for more innovation and what are the end-users looking for in their products?
- (Q). Will biodegradable stent systems fulfill these unmet needs? (Q). What is physician perception and market outlook of this technology?
- (Q). What percent of global profits are from emerging markets? (Q). How will this change in the future?
- Boston Scientific currently dominates the global non-vascular stents market. (Q). What is their market share in the major global economies and which companies constitute the remainder of the market?

Reasons to buy

- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading physicians and other stakeholders from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table Of Contents

Non-Vascular Stents - 5EU Analysis and Market Forecasts
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Industry Overview
3.1 Overview
3.2 Non-Vascular Stenting Indications
3.2.1 Enteral Stents
3.2.2 Pancreatic and Biliary Stents
3.2.3 Airway Stents
3.2.4 Urinary Tract Stents
3.3 Types of Stents and Clinical Efficacy
3.3.1 Enteral Stents
3.3.2 Pancreatic and Biliary Stents
3.3.3 Airway Stents
3.3.4 Urinary Tract Stents
3.4 Procedure Trends
3.4.1 5EU
3.5 Market Access
3.5.1 Product Adoption
3.5.2 Regulation
3.5.3 Reimbursement
3.6 Regulatory Issues/Recalls (2011-2014)
3.6.1 Cordis Corporation Class II Recall of S.M.A.R.T Control Transhepatic Biliary Stent
3.7 Mergers, Acquisitions, and Other Deals
3.7.1 Medtronic Acquires Covidien
3.7.2 Beijing King Health Signs Distribution Agreement With Allium Medical
3.7.3 Cordis Acquires Flexible Stenting Solutions
3.7.4 Allium Medical Enters Into Distribution Agreement With Meizler UCB Biopharma
3.7.5 Gore and ConMed Extend Distribution Agreement
3.7.6 Allium Medical Acquires Gardia Medical
3.7.7 Flexible Stenting Solutions Raises Funds in Series B Financing
3.8 Economic Impact
4 Unmet Needs
4.1 Addressing the Complications
4.1.1 Enteral Stents
4.1.2 Pancreatic and Biliary Stents
4.1.3 Airway Stents
4.1.4 Urinary Tract Stents
4.2 Overcoming Stent Design Challenges
4.2.1 Stent Shortening
4.2.2 Stent Fracture
4.2.3 Flexibility
4.3 Simplify Delivery Systems
4.4 Disconnect Between Industry and Physicians
4.5 Indication-Specific Stents
4.6 Lack of Long-Term and Comparative Clinical Data
4.7 Refocus on Pipeline Products
4.8 Lack of Standardization
4.9 Cost-Containment
4.10 Need for An International Procedure Registry
5 Market Opportunity Analysis
5.1 Improve Stent Systems
5.2 Biodegradable Stents
5.3 Drug-Eluting Stents
5.4 Radiosensitization
5.5 Customized Stents
5.6 Emerging Markets
6 Market Drivers and Barriers
6.1 Driver: Rising Disease Prevalence
6.1.1 Cancer
6.1.2 Urolithiasis
6.2 Driver: Non-Malignant Stenting Applications to Drive the Market
6.2.1 Drainage
6.2.2 Bariatric Surgery
6.2.3 Neoadjuvant Treatment
6.2.4 Benign Strictures
6.3 Driver: Fully-Covered, Removable Metal Stents To Drive Future Growth
6.4 Driver: Preference for Minimally-Invasive Solutions
6.5 Driver: Increased Life Expectancy
6.6 Driver: Technological Advancements
6.7 Driver: Patient Demand and Awareness
6.8 Driver: Rising Competition and Innovation
6.9 Barrier: Availability of Venture Capital
6.10 Barrier: Burden of Rising Regulation
6.11 Barrier: Proving Long-Term Efficacy
6.12 Barrier: Medical Device Excise Tax
7 Competitive Assessment
7.1 Gastrointestinal Stents
7.1.1 Overview
7.1.2 WallFlex (Boston Scientific Corporation)
7.1.3 Evolution (Cook Medical)
7.1.4 Niti-S (Taewoong Medical)
7.1.5 Other Key Marketed Gastrointestinal Stents
7.2 Biliary Stents
7.2.1 Overview
7.2.2 WallFlex Biliary RX (Boston Scientific Corporation)
7.2.3 Cotton-Leung (Amsterdam) (Cook Medical)
7.2.4 Bonastent (EndoChoice)
7.2.5 Other Key Marketed Biliary Stents
7.3 Airway Stents
7.3.1 Overview
7.3.2 Dumon (Novatech)
7.3.3 Aero/Aero DV (Merit Endotek)
7.3.4 Ultraflex (Boston Scientific Corporation)
7.3.5 Other Key Marketed Airway Stents
7.4 Urinary Tract Stents
7.4.1 Overview
7.4.2 Polaris Ultra (Boston Scientific Corporation)
7.4.3 InLay Optima (C.R. Bard)
7.4.4 Other Key Marketed Urinary Tract Stents
8 Clinical Trials to Watch
8.1 Overview
8.2 Enteral Stents
8.3 Pancreatic and Biliary Stents
8.4 Airway Stents
8.5 Urinary Tract Stents
9 Current and Future Players
9.1 Trends in Corporate Strategy
9.2 Company Profiles
9.2.1 Allium Medical
9.2.2 Boston Scientific Corporation
9.2.3 ConMed
9.2.4 Cook Medical
9.2.5 C.R. Bard
9.2.6 Ella-CS
9.2.7 Merit Endotek
9.2.8 M.I. Tech
9.2.9 Micro-Tech (Nanjing)
9.2.10 Medtronic (Covidien)
9.2.11 Novatech
9.2.12 Olympus
9.2.13 Taewoong Medical
9.2.14 Xlumena
9.2.15 Other Companies
10 Market Outlook
10.1 Company Market Share
10.1.1 5EU
10.2 By Market Segment
10.2.1 EU Overview
10.2.2 Enteral Stents
10.2.3 Pancreatic and Biliary Stents
10.2.4 Airway Stents
10.2.5 Urinary Tract Stents
10.3 By Geography
11 Appendix
11.1 Bibliography
11.2 Abbreviations
11.3 Research Methodology
11.3.1 Overview
11.3.2 Coverage
11.3.3 Secondary Research
11.4 Physicians and Specialists Included in this Study
11.5 Primary Research
11.5.1 Primary Research - Key Opinion Leader Interviews
11.5.2 Primary Research - Physician and Industry Interviews
11.5.3 Expert Panel Validation
11.6 Forecasting Methodology
11.7 About the Authors
11.7.1 Analysts
11.7.2 Global Head of Healthcare
11.8 About MediPoint
11.9 About GlobalData
11.10 Disclaimer

1.1 List of Tables
Table 1: Ideal Characteristics of a Stent
Table 2: Comparison of Silicone and Metal Airway Stents
Table 3: Enteral Stenting Procedure Volumes Forecast for the 5EU, 2011-2021
Table 4: Pancreatic and Biliary Stents Procedure Volumes Forecast for the 5EU, 2011-2021
Table 5: Airway Stenting Procedure Volumes Forecast for the 5EU, 2011-2021
Table 6: Urinary Tract Stenting Procedure Volumes Forecast for the 5EU, 2011-2021
Table 7: GPOs in the US and EU
Table 8: Regulatory Differences Between the US and EU for Obtaining Approval for Medical Devices
Table 9: Medicare National Average Reimbursement Rates for Non-Vascular Stenting Procedures, 2014
Table 10: Direct, Indirect, and Intangible Costs of Non-Vascular Stenting
Table 11: WallFlex Family Stent Product Portfolio
Table 12: WallFlex Stent Family SWOT Analysis
Table 13: Evolution Family Stent Product Portfolio
Table 14: Evolution Stent Family SWOT Analysis
Table 15: Niti-S Family Stent Product Portfolio
Table 16: Niti-S Stent Family SWOT Analysis
Table 17: Gastrointestinal Stents, Other Key Marketed Products
Table 18: WallFlex Biliary RX Stent Product Portfolio
Table 19: WallFlex Biliary RX Stent SWOT Analysis
Table 20: Cotton-Leung Stent Product Portfolio
Table 21: Cotton-Leung Stent SWOT Analysis
Table 22: Bonastent Product Portfolio
Table 23: Bonastent Stent SWOT Analysis
Table 24: Biliary Stents, Other Key Marketed Products
Table 25: Dumon Stent Product Portfolio
Table 26: Dumon Stent SWOT Analysis
Table 27: Aero/Aero DV Stent Product Portfolio
Table 28: Aero/Aero DV Stents SWOT Analysis
Table 29: Ultraflex Stent Product Portfolio
Table 30: Ultraflex Stent SWOT Analysis
Table 31: Airway Stents, Other Key Marketed Products
Table 32: Polaris Ultra Stent Product Portfolio
Table 33: Polaris Ultra Stent SWOT Analysis
Table 34: InLay Optima Stent Product Portfolio
Table 35: InLay Optima SWOT Analysis
Table 36: Urinary Tract Stents, Other Key Marketed Products
Table 37: Major Clinical Trials for Enteral Stents
Table 38: Major Clinical Trials for Pancreatic and Biliary Stents
Table 39: Major Clinical Trial for Airway Stents
Table 40: Company Profile - Allium Medical
Table 41: Allium Medical's Marketed Non-Vascular Stent Products
Table 42: SWOT Analysis - Allium Medical
Table 43: Company Profile - Boston Scientific Corporation
Table 44: Boston Scientific Corporation's Marketed Non-Vascular Stent Products
Table 45: SWOT Analysis - Boston Scientific Corporation
Table 46: Company Profile - ConMed
Table 47: ConMed, Key Marketed Non-Vascular Stent Products
Table 48: SWOT Analysis - ConMed
Table 49: Company Profile - Cook Medical
Table 50: Cook Medical, Key Marketed Non-Vascular Stent Products
Table 51: SWOT Analysis - Cook Medical
Table 52: Company Profile - C.R. Bard
Table 53: C.R. Bard, Key Marketed Non-Vascular Stent Products
Table 54: SWOT Analysis - C.R. Bard
Table 55: Company Profile - Ella-CS
Table 56: Ella-CS, Key Marketed Non-Vascular Stent Products
Table 57: SWOT Analysis - Ella-CS
Table 58: Company Profile - Merit Endotek
Table 59: Merit Endotek's Key Marketed Non-Vascular Stent Products
Table 60: SWOT Analysis - Merit Endotek
Table 61: SWOT Analysis - M.I. Tech
Table 62: Company Profile - Micro-Tech (Nanjing)
Table 63: Micro-Tech (Nanjing), Key Marketed Non- Vascular Stent Products
Table 64: SWOT Analysis - Micro-Tech (Nanjing)
Table 65: Medtronic (Covidien) Marketed Non-Vascular Stent Products
Table 66: SWOT Analysis - Medtronic (Covidien)
Table 67: Company Profile - Novatech
Table 68: Novatech's Marketed Non-Vascular Stent Products
Table 69: SWOT Analysis - Novatech
Table 70: Company Profile - Olympus
Table 71: Olympus' Key Marketed Non-Vascular Stent Products
Table 72: SWOT Analysis - Olympus
Table 73: Company Profile - Taewoong Medical
Table 74: Taewoong Medical Marketed Products
Table 75: SWOT Analysis - Taewoong Medical
Table 76: Company Profile - Xlumena
Table 77: Xlumena's Key Marketed Non-Vascular Stent Products
Table 78: SWOT Analysis - Xlumena
Table 79: Other Companies Involved in the Non-Vascular Stents Market, 2014
Table 80: Non-Vascular Stents Sales ($m) Forecast for the EU, 2011-2021
Table 81: Non-Vascular Stents Sales ($m) Forecast for France, 2011-2021
Table 82: Non-Vascular Stents Sales ($m) Forecast for Germany, 2011-2021
Table 83: Non-Vascular Stents Sales ($m) Forecast for Italy, 2011-2021
Table 84: Non-Vascular Stents Sales ($m) Forecast for Spain, 2011-2021
Table 85: Non-Vascular Stents Sales ($m) Forecast for the UK, 2011-2021
Table 86: Non-Vascular Stents - Primary Call Count by Country
Table 87: Non-Vascular Stents - Primary Call Count by Type

1.2 List of Figures
Figure 1: Enteral Stent - Esophageal
Figure 2: Biliary Stent
Figure 3: Bronchial Stent
Figure 4: Prostatic and Urethral Stents
Figure 5: Development Timeline for Esophageal Stents
Figure 6: Development Timeline for Gastroduodenal Stents
Figure 7: Development Timeline for Colorectal Stents
Figure 8: Enteral Stenting Procedure Volumes Forecast for the 5EU, 2011-2021
Figure 9: Enteral Stenting Procedure Volumes Forecast for the 5EU By Stent Type, 2013 and 2021
Figure 10: Pancreatic and Biliary Stenting Procedure Volumes Forecast for the 5EU, 2011-2021
Figure 11: Pancreatic and Biliary Stenting Procedure Volumes Forecast for the 5EU By Stent Type, 2013 and 2021
Figure 12: Airway Stenting Procedure Volumes Forecast for the 5EU, 2011-2021
Figure 13: Airway Stenting Procedure Volumes Forecast for the 5EU By Stent Type, 2013 and 2021
Figure 14: Urinary Tract Stenting Procedure Volumes Forecast for the 5EU, 2011-2021
Figure 15: Urinary Tract Stenting Procedures Forecast for the 5EU By Stent Type, 2013 and 2021
Figure 16: 5EU Non-Vascular Stents Market, By Company Share, 2013
Figure 17: US Non-Vascular Stents Market, By Segment, 2013 and 2021
Figure 18: Non-Vascular Stents Sales ($m) Forecast for the EU, 2011-2021
Figure 19: Non-Vascular Stents Sales ($m) Forecast for France, 2011-2021
Figure 20: French Non-Vascular Stents Market, 2013 and 2021
Figure 21: Non-Vascular Stents Sales ($m) Forecast for Germany, 2011-2021
Figure 22: German Non-Vascular Stents Market, 2013 and 2021
Figure 23: Non-Vascular Stents Sales ($m) Forecast for Italy, 2011-2021
Figure 24: Italian Non-Vascular Stents Market, 2013 and 2021
Figure 25: Non-Vascular Stents Sales ($m) Forecast for Spain, 2011-2021
Figure 26: Spanish Non-Vascular Stents Market, 2013 and 2021
Figure 27: Non-Vascular Stents Sales ($m) Forecast for the UK, 2011-2021
Figure 28: UK Non-Vascular Stents Market, 2013 and 2021
Figure 29: Non-Vascular Stents - Primary Call Count by Country
Figure 30: Non-Vascular Stents - Primary Call Count by Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
European Market Report for Central Venous Catheters 2017 - MedCore

European Market Report for Central Venous Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European CVC market includes acute and chronic CVCs. Acute CVCs are classified as either conventional acute CVCs or antimicrobial acute CVCs. The acute CVC market includes conventional ...

European Market Report for Dialysis Catheters 2017 - MedCore

European Market Report for Dialysis Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European market for dialysis catheters comprises the acute hemodialysis, chronic hemodialysis and peritoneal dialysis catheter segments. The chronic hemodialysis catheter market is segmented ...

Biodegradable Stents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Biodegradable Stents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Biodegradable Stents Market: Overview Biodegradable Stents are the third generation of stents used in the treatment of coronary artery diseases, which are completely absorbed in the body after the ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.